Tokyo, Japan

Toshiro Morohoshi

This inventor holds 1 USPTO granted patent. Top assignee: Sosei Co., Ltd.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshiro Morohoshi. Retrieved from https://idiyas.com/inventor/toshiro-morohoshi-76fopb1k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshiro Morohoshi: Innovator in Antitumor Research

Introduction

Toshiro Morohoshi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of antitumor research, particularly through his innovative patent that enhances the effectiveness of antitumor substances. His work is vital in the ongoing battle against cancer.

Latest Patents

Morohoshi holds a patent for a "GM-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent." This invention serves as an antitumor effect enhancer, which improves the antitumor effects of existing antitumor substances. The patent describes a compound that includes various functional groups, allowing for a versatile application in cancer treatment.

Career Highlights

Throughout his career, Toshiro Morohoshi has been associated with Sosei Co., Ltd., a company known for its commitment to innovative pharmaceutical solutions. His work has been instrumental in developing new therapies that aim to improve patient outcomes in cancer treatment.

Collaborations

Morohoshi has collaborated with notable colleagues, including Kazuo Shinya and Tetsuzo Tauchi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Toshiro Morohoshi's contributions to antitumor research exemplify the impact of innovation in medicine. His patent and collaborative efforts continue to pave the way for advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…